Here are five insights:
1. The offering was valued at 4.6 million common stock shares.
2. The offering included the full exercise for the underwriters to purchase 600,000 more shares at $13 per share.
3. On Oct. 12, these shares started trading on NASDAQ as “KIDS.”
4. Piper Jaffray and Stifel served as joint book-running managers, with William Blair acting as lead manager and BTIG as co-manager.
5. OrthoPediatrics develops products for the pediatric orthopedic market.
More articles on devices:
Arthrex to build $30M manufacturing plant in South Carolina: 5 insights
Johnson & Johnson medical device segment reports 4.9% sales growth in 2Q 2017 – to see greater growth in 3Q
Orthopaedic Implant Company launches external fixation system: 5 takeaways
